ENANTA PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits in USD from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Enanta Pharmaceuticals Inc quarterly Unrecognized Tax Benefits history and growth rate from Q3 2012 to Q3 2024.
  • Enanta Pharmaceuticals Inc Unrecognized Tax Benefits for the quarter ending September 30, 2024 was $905K, a 14.3% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $905K -$151K -14.3% Sep 30, 2024 10-K 2024-11-27
Q3 2023 $1.06M +$830K +367% Sep 30, 2023 10-K 2024-11-27
Q3 2022 $226K -$396K -63.7% Sep 30, 2022 10-K 2024-11-27
Q3 2021 $622K -$222K -26.3% Sep 30, 2021 10-K 2023-11-22
Q2 2021 $529K -$247K -31.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $686K -$78K -10.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $675K -$1M -59.8% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 $844K -$806K -48.8% Sep 30, 2020 10-K 2022-11-23
Q2 2020 $776K -$1.09M -58.4% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $764K -$1.16M -60.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.68M $0 0% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $1.65M -$29K -1.73% Sep 30, 2019 10-K 2021-11-24
Q2 2019 $1.87M +$372K +24.9% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $1.92M +$483K +33.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $1.68M +$491K +41.3% Dec 31, 2018 10-K 2020-11-25
Q3 2018 $1.68M +$504K +42.9% Sep 30, 2018 10-K 2019-11-27
Q2 2018 $1.49M +$384K +34.6% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $1.44M +$373K +35% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.19M +$123K +11.5% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 $1.18M +$430K +57.7% Sep 30, 2017 10-K 2019-11-27
Q2 2017 $1.11M +$441K +66% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.07M +$556K +109% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $1.07M +$567K +114% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $745K +$297K +66.3% Sep 30, 2016 10-K 2018-11-29
Q2 2016 $668K +$568K +568% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $510K +$510K Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $498K +$498K Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $448K +$448K Sep 30, 2015 10-K 2017-12-11
Q2 2015 $100K Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $0 Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $0 Dec 31, 2014 10-Q 2015-02-06
Q3 2014 $0 $0 Sep 30, 2014 10-K 2015-12-11
Q3 2013 $0 $0 Sep 30, 2013 10-K 2014-12-11
Q3 2012 $0 Sep 30, 2012 10-K 2014-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.